6533b81ffe1ef96bd1278ff5
RESEARCH PRODUCT
Additional File 12:
Francesca MonteleoneSimona TavernaRiccardo AlessandroSimona Fontanasubject
hemic and lymphatic diseasesneoplasmsdescription
Figure S7. Anti-proliferative effects of curcumin, imatinib and curcumin+imatinib combination on CML cell viability. Curcumin and imatinib were tested for their anti-proliferative effects on K562 (a) and LAMA84 cells (b). The assays were performed by using curcumin and imatinib singly (using the reported doses) or in combination (20 μM curcumin held constant and imatinib at reported concentrations. In K562 cells combination compound treatments showed significant differences compared to single imatinib treatments for all doses tested (p 1 indicates antagonism. (PPTX 50 kb)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-01-01 |